Stevanato Group (NYSE:STVN) Given New $19.00 Price Target at Morgan Stanley

Stevanato Group (NYSE:STVN) had its target price trimmed by Morgan Stanley from $24.00 to $19.00 in a research note published on Friday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

A number of other brokerages have also issued reports on STVN. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stevanato Group in a report on Monday, December 29th. Citigroup dropped their target price on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday. KeyCorp cut their target price on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday. Jefferies Financial Group set a $17.50 price target on shares of Stevanato Group in a report on Tuesday, February 10th. Finally, Wall Street Zen cut shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Stevanato Group presently has a consensus rating of “Moderate Buy”.

Stevanato Group Price Performance

STVN traded down €0.45 on Friday, hitting €15.46. 596,200 shares of the company’s stock traded hands, compared to its average volume of 749,502. The company’s 50 day simple moving average is €17.58 and its 200-day simple moving average is €21.66. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.23. Stevanato Group has a one year low of €13.91 and a one year high of €28.00. The firm has a market cap of $4.68 billion, a price-to-earnings ratio of 26.66, a P/E/G ratio of 1.46 and a beta of 0.57.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Farther Finance Advisors LLC purchased a new stake in Stevanato Group during the third quarter valued at $44,000. GW&K Investment Management LLC increased its holdings in shares of Stevanato Group by 76.2% in the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after buying an additional 1,055 shares during the last quarter. First Horizon Corp purchased a new stake in shares of Stevanato Group during the 3rd quarter valued at about $50,000. State of Wyoming raised its position in shares of Stevanato Group by 39,216.7% during the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after buying an additional 2,353 shares in the last quarter. Finally, Quantbot Technologies LP bought a new position in shares of Stevanato Group in the 3rd quarter valued at about $68,000.

More Stevanato Group News

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Q4 beats and revenue momentum — Stevanato reported Q4 results that beat expectations (reported EPS ~$0.2114 vs. ~$0.20 consensus) and highlighted strong revenue growth, reinforcing demand for its pharmaceutical packaging and high‑value solutions. STVN Q4 Highlights
• Positive Sentiment: 2026 guidance and HVS mix — Management outlined a 2026 revenue target up to €1.308B and expects high‑value solutions (HVS) to reach ~48% of sales, supporting margin expansion potential as capex is mainly HVS‑directed. 2026 Revenue Target Article
• Positive Sentiment: Analyst buy support — At least one note (Seeking Alpha piece) reiterates a Buy thesis citing Q4/FY25 strength and long‑term demand drivers, framing current weakness as cyclical in the Engineering segment. Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story
• Neutral Sentiment: Earnings call detail — Full Q4/FY25 earnings call transcripts and summaries are available for deeper read; they provide management color on capex allocation (heavy toward HVS) and the cyclical pressure in Engineering. Useful for modeling near‑term margin recovery timing. Q4 2025 Earnings Call Summary
• Neutral Sentiment: Transcripts published — Full call transcripts (Seeking Alpha / InsiderMonkey) confirm the beat and provide verbatim management commentary for investors building scenarios. Earnings Call Transcript
• Negative Sentiment: Multiple analyst price‑target cuts — Morgan Stanley cut its PT to $19 and moved to Equal Weight; Citigroup lowered its PT to $26 (maintained Buy); KeyCorp trimmed its PT to $32 (keeps Overweight). Those revisions reduce near‑term upside expectations and likely contributed to selling pressure. Analyst PT Changes (Benzinga) KeyBanc / StreetInsider

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.